Crispr Therapeutics shares owned by Capital Impact Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital Impact Advisors
from 13F filings
Historical chart of Capital Impact Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Capital Impact Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $518k | 7.6k | 68.16 |
2023-12-31 | $915k | 15k | 62.60 |
2023-06-30 | $461k | 8.2k | 56.14 |
2023-03-31 | $371k | 8.2k | 45.23 |
2021-12-31 | $26k | 3.5k | 7.49 |
2021-06-30 | $7.4M | 45k | 161.88 |
2020-09-30 | $5.9M | 70k | 83.64 |